etoposide has been researched along with Sarcoma in 132 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (8.33) | 18.7374 |
1990's | 47 (35.61) | 18.2507 |
2000's | 45 (34.09) | 29.6817 |
2010's | 19 (14.39) | 24.3611 |
2020's | 10 (7.58) | 2.80 |
Authors | Studies |
---|---|
Kakikawa, M; Shibaki, R | 1 |
Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY | 1 |
Alva, E; Bukowinski, A; Cramer, SL; Daley, J; Escoto, H; Fair, D; Hartt, D; Kim, H; LeBlanc, Z; Merjaneh, N; Metts, J; Pressey, JG; Ray, A; Szabo, S; Todd, K; Watanbe, M | 1 |
Ahmed, SK; Allen-Rhoades, W; Heidenreich, MJ; Houdek, MT; Petersen, IA; Robinson, SI; Rose, PS; Siontis, BL | 1 |
Ebinger, M; Fuchs, J; Heinz, AT; Klingebiel, T; Koscielniak, E; Kratz, CP; Ljungman, G; Münter, MW; Pajtler, KW; Rößler, J; Schönstein, A; Seitz, G; Sparber-Sauer, M; Stegmaier, S; Timmermann, B; Vokuhl, C; von Kalle, T | 1 |
Batur, A; Isik Bedir, S; Karabagli, H; Karabagli, P; Koksal, Y; Ozturk, M; Yavas, G | 1 |
Ebinger, M; Fuchs, J; Heinz, AT; Juntti, H; Klingebiel, T; Koscielniak, E; Kratz, CP; Ljungman, G; Münter, M; Pajtler, KW; Schönstein, A; Seitz, G; Sparber-Sauer, M; Stegmaier, S; Timmermann, B; Vokuhl, C; von Kalle, T | 1 |
Hao, J; Jing, Y; Wu, W; Xu, Q | 1 |
Bassale, S; Davis, LE; Lim, JY; Lu, E; Ryan, CW | 1 |
Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM | 1 |
Abdel-Rahman, S; Angele, M; Belka, C; Daugaard, S; Dürr, HR; Ghadjar, P; Gronchi, A; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Knösel, T; Lindner, LH; Mansmann, U; Mella, O; Reichardt, P; Salat, C; Schmidt, M; Verweij, J; Vujaskovic, Z; Wessalowski, R; Wust, P | 1 |
Banavali, S; Devadas, SK | 1 |
Bartz, PJ; Collins, CL; Lal, DR; Segura, AD; Tower, RL; Woods, RK | 1 |
Bischof, M; Debus, J; Egerer, G; Grüllich, C; Hensley, FW; Huber, PE; Kasper, B; Lehner, B; Mechtersheimer, G; Roeder, F; Schmitt, T; Sedlaczek, O; Wuchter, P | 1 |
Barber, J; Coutermarsh-Ott, S; Feldhaeusser, B; Gogal, R; Hill, J; Lawrence, J; Saba, C; Smith, J; Turek, M | 1 |
Blomen, V; Brummelkamp, TR; Hoogstraat, M; Janssen, L; Lips, EH; Neefjes, J; Pang, B; Qiao, X; van der Zanden, SY; Wessels, L; Wijdeven, RH | 1 |
Bartels, U; Bouffet, E; Hader, W; Hawkins, C; Lafay-Cousin, L; Laperriere, N; Laughlin, S; Lindzon, G; Nordal, R; Taylor, MD | 1 |
Kaneko, T; Koike, K; Kurata, T; Motobayashi, M; Nakazawa, Y; Sano, K; Shigemura, T; Sumi, T; Suzuki, S; Watanabe, T | 1 |
Baek, SW; Choi, YS; Jo, DY; Kim, S; Lee, HJ; Moon, JY; Ryu, H; Song, IC; Yun, HJ | 1 |
Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N | 1 |
Baba, S; Hosokawa, S; Mineta, H; Suzuki, K; Takebayashi, S | 1 |
Bielack, SS; Brecht, I; Dantonello, TM; Dickerhoff, R; Gadner, H; Greiner, J; Greulich, M; Harms, D; Herbst, M; Int-Veen, C; Juergens, H; Kirsch, S; Klingebiel, T; Koscielniak, E; Leuschner, I; Marky, I; Scheel-Walter, HG; Schmelzle, R; Schmidt, BF; Treuner, J | 1 |
Abdel-Rahman, S; Issels, RD; Lindner, LH; Reiser, MF; Santl, M; Stahl, R; Wang, T | 1 |
Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
Anderson, JR; Huh, WW; Raney, RB; Rodeberg, D; Teot, L; Yock, T | 1 |
Bui, B; Coindre, JM; Garbay, D; Italiano, A; Kantor, G; Kind, M; Lortal, B; Stoeckle, E; Toulmonde, M | 1 |
Arnold, D; Behlendorf, T; Jordan, K; Kegel, T; Mueller, LP; Schmoll, HJ; Sippel, C; Voigt, W; Wolf, HH | 1 |
Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Lehner, B; Mechtersheimer, G; Schmitt, T; Strauss, LG; Stroebel, P; Vasamiliette, J | 1 |
Abdel-Rahman, S; Baur-Melnyk, A; Blay, JY; Daugaard, S; Dürr, HR; Hiddemann, W; Hohenberger, P; Issels, RD; Jauch, KW; Lindner, LH; Mansmann, U; Ploner, F; Reichardt, P; Salat, C; Schem, BC; Verweij, J; Vujaskovic, Z; Wendtner, CM; Wessalowski, R; Wust, P | 1 |
Chae, M; Kang, HS; Kim, HS; Kim, JH; Kim, WK; Kim, YJ; Yoon, S | 1 |
Bay, JO; Blay, JY; Bonichon, F; Bui-Nguyen, B; Chevreau, C; Coindre, JM; Cupissol, D; Italiano, A; Jimenez, M; Lotz, JP; Mathoulin-Pélissier, S; Penel, N; Ray-Coquard, I; Thyss, A | 1 |
Bischof, M; Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Lehner, B; Mechtersheimer, G; Roeder, F; Schmitt, T; Strauss, LG; Wuchter, P | 1 |
Chan, AW; Cianchetti, M; Deschler, DG; Liebsch, NJ; Varvares, MA; Wang, JJ | 1 |
Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC | 1 |
Abdel-Rahman, S; Baumert, J; Baur, A; Hiddemann, W; Issels, RD; Krych, M; Lindner, LH; Wendtner, CM | 1 |
Berland, B; Cohen, C; Le Tortorec, S; Potier, P; Pozzo, A; Saint-Marc, O | 1 |
Douglas, J; Felgenhauer, J; Gooley, T; Hawkins, DS; Kreissman, S; Park, J; Pendergrass, TW; Rowley, SD; Sanders, JE; Thomson, B | 1 |
Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 1 |
Starkhammar, H; Wall, N | 1 |
Bailey, H; Bakhshandeh, A; Finet, J; Gillis, W; Jager, D; Jager, E; Katschinski, DM; Knuth, A; Longo, W; Neumann, A; Peters, SO; Robins, HI; Tiggelaar, CL; Van Dijk, JD; Vörde Sive Vörding, PZ; Westermann, AM; Wiedemann, GJ | 1 |
Hitchcock, RJ; Mitchell, CD; Patel, Y | 1 |
Ayan, I; Görgün, O; Kebudi, R | 1 |
Choi, SH; Hong, SY; Hyung, WJ; Jung, HC; Kim, KS; Lee, MH; Noh, SH; Roh, JK | 1 |
Abdel-Rahman, S; Fahn, W; Fiegl, M; Issels, RD; Schlemmer, M; Wendtner, CM | 1 |
Chuman, H | 1 |
Anderson, B; Angiolillo, A; Cairo, MS; Cheung, YK; Davenport, V; Krailo, M; Reaman, G; Van Winkle, P | 1 |
Abadie-Lacourtoisie, S; Catala, L; Descamps, P; Lortholary, A; Morand, C; Paillocher, N; Verriele, V | 1 |
Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
Boddy, AV; Errington, J; Lowis, S; Thomas, HD; Veal, GJ | 1 |
Billups, CA; Cain, AM; Furman, WL; Hale, GA; Merchant, TE; Navid, F; Pappo, AS; Rao, BN; Santana, VM; Spunt, SL | 1 |
Frater, JL; Gardner, LJ; Grosso, LE; Hurley, MY; Kling, CW; Obadiah, JM; Resh, B | 1 |
Budach, V; Felix, R; Ganter, H; Gellermann, J; Hildebrandt, B; Issels, R; Reichardt, P; Tunn, PU; Wlodarczyk, W; Wust, P | 1 |
Admirand, JH; Bueso-Ramos, CE; Ford, RJ; Jiang, L; Moran, C | 1 |
Abdel-Rahman, S; Baumert, J; Falk, M; Hentrich, M; Hiddemann, W; Issels, RD; Licht, T; Salat, C; Schlemmer, M; Straka, C; Wendtner, CM | 1 |
Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Markaki, S; Papadimitriou, CA; Rodolakis, A; Voulgaris, Z; Zorzou, MP | 1 |
Abidi, MH; Ibrahim, RB; Maria, D; Peres, E; Tove, I | 1 |
Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Ho, AD; Kasper, B; Strauss, LG | 1 |
Cheerva, AC; Gross, TG; Kadota, RP; Levine, JE; Ozkaynak, MF; Richards, MK; Rozans, MK; Sahdev, I; Shaw, PJ | 1 |
Jungi, WF | 1 |
Dimitriadis, K; Schmidt, CG; Schütte, J; Seeber, S | 1 |
Saeter, G; Solheim, OP; Talle, K | 1 |
Ayash, LJ; Elias, AD; Frei, E; Gonin, R; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C | 1 |
Cairo, MS | 1 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC | 1 |
Balis, FM; Bates, SE; Bryant, G; Chabner, BA; Jamis-Dow, C; Klecker, RW; Kohler, DR; Steinberg, SM; Wilson, WH; Wittes, RE | 1 |
Flamant, F; Phillips, MB; Pinkerton, CR; Sommelet-Olive, D | 1 |
Ahn, DC; Doroshow, JH; Forman, SJ; Hwang, L; Leong, LA; Lev-Ran, A; Margolin, KA; Morgan, RJ; Raschko, JW; Somlo, G | 1 |
Ballester, OF; Cooper, BW; Creger, RJ; Elfenbein, GJ; Fields, KK; Hiemenz, JH; Janssen, WE; Lazarus, HM; Perkins, JB; Zorsky, PE | 1 |
Baker, LH; Blair, SC; Zalupski, MM | 1 |
Adler, SS; Feingold, JM; Ghalie, R; Kaizer, H; Korenblit, AD; Manson, S; Pruett, J; Reynolds, J; Valentino, LA | 1 |
Chen, KG; Durán, GE; Jaffrézou, JP; Kühl, JS; Sikic, BI | 1 |
Goodin, S; Gosland, M; Hoffman, T; Tsuboi, C; Vore, M | 1 |
Davidson, A; Lewis, I; Pearson, AD; Pinkerton, CR; Stevens, MC | 1 |
Antman, KH; Gonin, R; Licht, JD; Loehrer, PJ; Mazanet, R | 1 |
Hamdan, H; Skubitz, KM; Thompson, RC | 1 |
Craft, AW; Pearson, AD; Yule, SM | 1 |
Bouffet, E; Bouhour, D; Brunat-Mentigny, M; Carrie, C; Frappaz, D; Grabois, M; Philip, T | 1 |
Hibi, S; Imashuku, S; Kataoka, Y; Morimoto, M; Naya, M; Takaya, K; Todo, S | 1 |
Aherne, GW; Dick, G; Pinkerton, CR | 1 |
Cole, M; Lowis, SP; Newell, DR; Pearson, AD | 1 |
Bell, DR; Dalley, D; Levi, J; Simes, RJ; Stuart-Harris, R; Wiltshaw, E | 1 |
Kellner, R; Schütte, J; Seeber, S | 1 |
Abdel-Rahman, S; Berger, H; Bosse, D; Issels, RD; Jauch, KW; Panzer, M; Peter, K; Sauer, H; Starck, M; Stiegler, H | 1 |
Baker, LH; Zalupski, MM | 1 |
Aziz, SM; Crooks, PA; Gillespie, MN; Gosland, MP; Olson, JW; Tofiq, S; Tsuboi, CP | 1 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L | 1 |
Crahé, R; Deeken, M; Eleftheriadis, S; Gutsche, S; Katschinski, DM; Mentzel, M; Robins, HI; Storer, B; Wagner, T; Weiss, C; Wiedemann, GJ | 1 |
Katschinski, DM; Mentzel, M; Mulkerin, DL; Robins, HI; Touhidi, R; Wiedemann, GJ | 1 |
Colvin, OM | 1 |
Verweij, J | 1 |
Alvegård, TA; Erlanson, M; Hannisdal, E; Klepp, R; Monge, OR; Raabe, N; Saeter, G; Söderberg, M; Solheim, OP; Strander, H; Turesson, I; Wist, E | 1 |
Chan, HS; Doyle, J; Greenberg, ML; Karaskov, V; Koren, G; Malkin, D; Moncica, I; Theis, JG | 2 |
Hess, CF; Jürgens, H; Klingebiel, T; Koscielniak, E; Pertl, U; Pötter, R; Rossi, R; Schött, C; Spaar, HJ; Treuner, J; van Heek-Romanowski, R; Willnow, U | 1 |
Barişta, I; Celik, I; Güllü, I; Kars, A; Ozişik, Y; Tekuzman, G; Yalçin, S | 1 |
Budman, DR; Calabro, A; Kreis, W | 1 |
Arndt, CA; Miser, JS; Moertel, CL; Nascimento, AG; Neglia, JP; Schomberg, PJ; Schroeder, G; Sencer, SF; Silberman, TL; Tillisch, JK | 1 |
Yalçin, S | 2 |
Alvegård, TA; Fernberg, JO; Hall, KS; Monge, O; Saeter, G; Strander, H; Wiklund, T | 1 |
Conrad, EU; Felgenhauer, J; Hawkins, D; Lindsley, K; Miser, JS; Pendergrass, T | 1 |
Daller, RT; Fenton, JG; Miser, JS; Womer, RB | 1 |
Filejski, W; Gerke, P; Robins, HI; Steinhoff, J; Wiedemann, GJ | 1 |
Hamana, T; Miyagi, N; Takahashi, M | 1 |
Bash, RO; Herrera, L; Kamen, BA; Leavey, PJ; Mantadakis, E; Winick, NJ | 1 |
Bodoky, G; Eckhardt, S; Láng, I; Pápai, Z; Poller, I; Rahóty, P; Szántó, J; Szendroi, M | 1 |
Beketic-Oreskovic, L; Chen, GK; Durán, GE; Mangili, A; Sikic, BI | 1 |
Barriga, F; García, C; González, S; Holmgren, NL; Méndez, M; Sánchez, I | 1 |
Biron, P; Blay, JY; Bouhour, D; Dumontet, C; Philip, T; Ray-Coquard, I | 1 |
Abdel-Rahman, S; Aydemir, U; Falk, MH; Hiddemann, W; Issels, RD; Kurze, V; Sauer, H; Wendtner, C | 1 |
Abdel-Rahman, S; Baumert, J; Falk, MH; Hiddemann, W; Issels, RD; Krych, M; Santl, M; Wendtner, C | 1 |
Bertino, JR; Cordon-Cardo, C; Elisseyeff, Y; Faircloth, G; Jhanwar, S; Jimeno, J; Li, WW; Takahashi, N | 1 |
Bai, P; Sun, J; Zhang, W | 1 |
Anderson, JR; Barr, FG; Crist, WM; Donaldson, SS; Maurer, HM; Pappo, AS; Qualman, SJ; Raney, RB; Wiener, ES | 1 |
Arnold, AM | 1 |
Fujita, J; Fujita, T; Irino, S; Kubo, A; Morikawa, N; Shiotani, T; Takahara, J; Takigawa, K; Yamagishi, Y; Yamaji, Y | 1 |
Foster, J; Kampe, CE; Lowenbraun, S; Rosen, G | 1 |
Biron, P; Blay, JY; Bouffet, E; Brunat-Mentigny, M; Chauvin, F; Clavel, M; Dumontet, C; Meckenstock, R; Philip, I; Philip, T | 1 |
Phillips, MB; Pinkerton, CR | 1 |
Gonzalez-Vela, JL; Kennedy, BJ; Manivel, JC; Savage, PD; Torkelson, JL | 1 |
Denzlinger, C; Gerl, A; Issels, RD; Mittermüller, J; Ortmaier, A; Sauer, H; Simon, W; Wilmanns, W | 1 |
Berger, H; Boehm, E; Denecke, H; Issels, RD; Jauch, KW; Nagele, A; Peter, K; Prenninger, SW; Sauer, H; Wilmanns, W | 1 |
Iqbal, Z; Mallick, JA; Zaidi, SH | 1 |
Raffin, TA; Sikic, BI; Yamauchi, T; Yang, P | 1 |
Buckner, JC; Edmonson, JH; Long, HJ; Loprinzi, CL; Schaid, DJ | 1 |
Ajani, JA; Baker, FL; Blaauw, AA; Dicke, KA; Spitzer, G; Thielvoldt, D; Tomasovic, B; Umbach, G; Zander, AR | 1 |
Gosland, MP; Lum, BL; Sikic, BI | 1 |
Forquer, R; Jarosinski, P; Kinsella, TJ; Magrath, I; Miser, JS; Triche, TJ; Tsokos, M; Wesley, R | 1 |
Calculli, G; Carli, M; Ceci, A; De Bernardi, B; di Montezemolo, LC; Di Tullio, MT; Grotto, P; Paolucci, G; Perilongo, G; Pianca, C | 1 |
Bramwell, V; Buesa, J; Dombernowsky, P; Mouridsen, H; Onsrud, M; Pinedo, HM; Rouesse, J; Santoro, A; Somers, R; Thomas, D | 1 |
Raney, RB | 1 |
7 review(s) available for etoposide and Sarcoma
Article | Year |
---|---|
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids | 2004 |
[Low-grade endometrial stromal sarcoma: contribution of hormone therapy and etoposide].
Topics: Antineoplastic Agents, Phytogenic; Endometrial Neoplasms; Etoposide; Female; Humans; Middle Aged; Pregnancy; Progestins; Sarcoma | 2005 |
The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Neoplasms; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Wilms Tumor | 1995 |
Drug resistance in the treatment of sarcomas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Paclitaxel; Platinum Compounds; Sarcoma | 1997 |
Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Prognosis; Registries; Remission Induction; Risk Factors; Sarcoma; Scandinavian and Nordic Countries; Soft Tissue Neoplasms; Treatment Outcome | 1999 |
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Melphalan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Topotecan; Treatment Outcome; Vincristine | 2001 |
Podophyllotoxin derivative VP 16-213.
Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma | 1979 |
49 trial(s) available for etoposide and Sarcoma
Article | Year |
---|---|
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Progression-Free Survival; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Young Adult | 2018 |
Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Topics: Administration, Metronomic; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Sarcoma, Ewing; Survival Rate; Tamoxifen; Young Adult | 2019 |
Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Germany; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Sarcoma; Soft Tissue Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2014 |
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms; Vincristine; Young Adult | 2009 |
Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Sarcoma; Soft Tissue Neoplasms; Thermography; Treatment Outcome | 2009 |
"Metronomic" chemotherapy in advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Sarcoma; Treatment Outcome | 2010 |
Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Discriminant Analysis; Doxorubicin; Etoposide; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoadjuvant Therapy; Patient Selection; Radionuclide Imaging; Risk; Sarcoma; Time Factors; Treatment Outcome | 2010 |
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retroperitoneal Neoplasms; Sarcoma; Survival Rate; Young Adult | 2010 |
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Consolidation Chemotherapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2012 |
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2011 |
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine | 2012 |
Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiography; Retroperitoneal Neoplasms; Sarcoma; Survival Analysis; Treatment Outcome; Viscera | 2002 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lenograstim; Male; Middle Aged; Recombinant Proteins; Sarcoma; Survival Analysis; Treatment Outcome | 2003 |
Oral etoposide for recurrent/progressive sarcomas of childhood.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease Progression; Etoposide; Female; Humans; Male; Neoplasms, Second Primary; Palliative Care; Recurrence; Remission Induction; Sarcoma; Survival Rate; Treatment Outcome | 2004 |
Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasm Staging; Patient Selection; Salvage Therapy; Sarcoma; Survival Rate; Thrombocytopenia; Treatment Outcome | 2004 |
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Colony-Stimulating Factors; Etoposide; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Proportional Hazards Models; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Rate | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Vincristine | 2006 |
Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Hyperthermia, Induced; Ifosfamide; Magnetic Resonance Imaging; Monitoring, Physiologic; Reproducibility of Results; Sarcoma; Thermography; Treatment Outcome | 2006 |
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Transplantation, Autologous | 2006 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2008 |
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Kidney Neoplasms; Melphalan; Neoplasms; Neuroblastoma; Pilot Projects; Recurrence; Risk Factors; Sarcoma; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Wilms Tumor | 2008 |
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Digestive System; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Nervous System; Ovarian Neoplasms; Sarcoma; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1995 |
Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Adenoid Cystic; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma | 1995 |
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Hypotension; Leukocyte Count; Lymphoma; Male; Middle Aged; Neutrophils; Platelet Count; Prednisone; Sarcoma; Stereoisomerism; Verapamil; Vincristine | 1995 |
Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Male; Neoplasm, Residual; Rhabdomyosarcoma; Sarcoma | 1995 |
Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Creatinine; Cyclophosphamide; Dopamine; Double-Blind Method; Electrolytes; Epidermal Growth Factor; Etoposide; Female; Hearing Loss; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sarcoma; Soft Tissue Neoplasms; Water-Electrolyte Imbalance | 1995 |
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Tolerance; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Ovarian Neoplasms; Prognosis; Sarcoma; Testicular Neoplasms; Transplantation, Autologous | 1995 |
Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Leiomyosarcoma; Male; Middle Aged; Sarcoma; Survival Analysis | 1994 |
Phase IV trial of daily oral etoposide in the treatment of advanced soft-tissue sarcoma.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Sarcoma | 1994 |
Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusion Pumps; Infusions, Intravenous; Male; Mesna; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms | 1993 |
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomas.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Sarcoma; Stomatitis; Treatment Outcome | 1995 |
Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma | 1996 |
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cross-Over Studies; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Lung Neoplasms; Male; Neutropenia; Platelet Count; Sarcoma | 1997 |
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Recombinant Proteins; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Treatment Outcome | 1997 |
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Cyclophosphamide; Cyclosporine; Dactinomycin; Drug Interactions; Etoposide; Fever; Humans; Ifosfamide; Immunosuppressive Agents; Neutropenia; Patient Admission; Retrospective Studies; Sarcoma; Sepsis; Soft Tissue Neoplasms; Vincristine | 1998 |
Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma | 1998 |
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Mouth Mucosa; Neoplasm Metastasis; Neutropenia; Prospective Studies; Remission Induction; Sarcoma; Stomatitis; Time Factors; Treatment Outcome; Vincristine | 2000 |
[Effectiveness of carboplatin and etoposide selective intra-arterial chemotherapy for progressive soft-tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 2000 |
Fractionated cyclophosphamide and etoposide for children with advanced or refractory solid tumors: a phase II window study.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasms; Sarcoma | 2000 |
The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 2000 |
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Pilot Projects; Prospective Studies; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 2000 |
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome | 2001 |
Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Sarcoma; Treatment Outcome | 2001 |
[Combination chemotherapy of uterine sarcomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Mitolactol; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Retrospective Studies; Sarcoma; Survival Rate; Uterine Neoplasms | 2000 |
Podophyllotoxin derivative VP 16-213.
Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma | 1979 |
Ifosfamide in soft tissue sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Sarcoma; Soft Tissue Neoplasms | 1990 |
77 other study(ies) available for etoposide and Sarcoma
Article | Year |
---|---|
Different effects of magnetic field on drug activity in human uterine sarcoma cell lines MES-SA and MES-SA/Dx5.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Magnetic Fields; Sarcoma; Uterine Neoplasms | 2022 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; Pancreas; Pancreatic Neoplasms; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2022 |
Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations.
Topics: Biomarkers, Tumor; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Repressor Proteins; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine | 2023 |
Treatment outcomes of extraskeletal Ewing sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Male; Sarcoma; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2023 |
Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chronic Disease; Cyclophosphamide; Etoposide; Humans; Polyketides; Recurrence; Retrospective Studies; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Topotecan | 2023 |
Radiation-induced Desmoid Tumor Development in the Radiotherapy Field in a Child With Pineoblastoma: A Case Report.
Topics: Brain Neoplasms; Child; Etoposide; Female; Fibromatosis, Aggressive; Humans; Pineal Gland; Pinealoma; Sarcoma | 2023 |
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Humans; Registries; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Risk Factors; Sarcoma; Soft Tissue Neoplasms | 2024 |
Therapy-related acute myeloid leukemia secondary to histiocytic sarcoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary; Polyethylene Glycols; Prednisone; Sarcoma; Vincristine | 2021 |
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Humans; Ifosfamide; Middle Aged; Retrospective Studies; Sarcoma; Vincristine; Young Adult | 2020 |
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine | 2020 |
Significant response to oral Etoposide in the treatment of an unresectable cardiac sarcoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Biopsy; Child; Etoposide; Female; Heart Neoplasms; Humans; Remission Induction; Sarcoma | 2014 |
In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cat Diseases; Cats; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Therapy, Combination; Etoposide; In Vitro Techniques; Neoplasms, Connective Tissue; Sarcoma | 2014 |
Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Capecitabine; Carcinoma; Chromosomal Proteins, Non-Histone; CRISPR-Cas Systems; Cyclophosphamide; DNA Helicases; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Profiling; Genome-Wide Association Study; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Neoplasm Proteins; Nuclear Proteins; RNA Interference; RNA, Small Interfering; Sarcoma; SMARCB1 Protein; Taxoids; Topoisomerase II Inhibitors; Topotecan; Transcription Factors; Triple Negative Breast Neoplasms | 2015 |
Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Canada; Carboplatin; Cerebrum; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Intracranial Hemorrhages; Male; Neurofibromatoses; Retrospective Studies; Sarcoma; Treatment Outcome | 2016 |
Dramatic Reduction in Tumor Size During 5 Months of Pazopanib Therapy in Combination With Ifosfamide, Carboplatin, and Etoposide in an Early Infant With Progressive Soft Tissue Sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Indazoles; Infant; Male; Pyrimidines; Remission Induction; Sarcoma; Sulfonamides | 2017 |
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Podophyllotoxin; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2017 |
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; Clonazepam; Etoposide; Female; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Retrospective Studies; Risk Factors; Sarcoma; Seizures; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2008 |
Undifferentiated sarcoma of the maxillary sinus: report of a rare case in an adult.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Male; Maxillary Sinus Neoplasms; Mesna; Middle Aged; Protective Agents; Sarcoma; Vincristine | 2009 |
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2009 |
Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiotherapy; Sarcoma; Treatment Outcome; Vincristine | 2010 |
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2010 |
Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Comet Assay; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hep G2 Cells; Humans; In Situ Nick-End Labeling; Proteasome Endopeptidase Complex; Pyrans; Sarcoma; Uterine Neoplasms | 2011 |
Risk of sinonasal-cutaneous fistula after treatment for advanced sinonasal cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cutaneous Fistula; Etoposide; Female; Fistula; Follow-Up Studies; Humans; Male; Middle Aged; Nasal Cavity; Neuroectodermal Tumors; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms; Paranasal Sinuses; Postoperative Complications; Radiotherapy; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma; Young Adult | 2012 |
[Gastric interdigitating reticulum cell sarcoma: unusual presentation of a histiocytic tumor].
Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Diagnosis, Differential; Etoposide; Gastrectomy; Histiocytes; Humans; Immunohistochemistry; Male; Methylprednisolone; Middle Aged; Sarcoma; Stomach Neoplasms | 2002 |
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Mesna; Neoplasm Metastasis; Remission Induction; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2002 |
Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gallium; Humans; Ifosfamide; Male; Middle Aged; Palliative Care; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2003 |
Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Kidney Neoplasms; Liver Neoplasms; Nephroma, Mesoblastic; Sarcoma; Vincristine | 2003 |
Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Drug Synergism; Endostatins; Endothelium, Vascular; Enzyme Inhibitors; Etoposide; Gene Expression; Genetic Therapy; Humans; Liver Neoplasms; Mice; Sarcoma; Survival Rate; Topoisomerase Inhibitors; Umbilical Veins | 2004 |
Biliary excretion of etoposide in children with cancer.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Bile; Child, Preschool; Drainage; Etoposide; Female; Humans; Male; Metabolic Clearance Rate; Sarcoma | 2006 |
Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a: evidence of indeterminate cell differentiation?
Topics: Antigens, CD1; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cell Proliferation; Cell Transformation, Neoplastic; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Histiocytes; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Sarcoma; Skin Neoplasms; Tonsillar Neoplasms; Vincristine | 2006 |
Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Dendritic Cells, Follicular; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Immunoenzyme Techniques; Mediastinal Neoplasms; Methotrexate; Middle Aged; Sarcoma; Taxoids; Treatment Outcome | 2006 |
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2007 |
Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histiocytes; Humans; Middle Aged; Prednisone; Retroperitoneal Neoplasms; Sarcoma; Thalidomide; Vincristine | 2007 |
Etoposide single-agent chemotherapy for solid tumors.
Topics: Carcinoma, Hepatocellular; Etoposide; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Sarcoma; Soft Tissue Neoplasms | 1982 |
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Small Cell; Cell Line; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Humans; Ifosfamide; Male; Naphthacenes; Sarcoma; Teratoma; Testicular Neoplasms; Vinca Alkaloids; Vincristine | 1984 |
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Neoplasm Staging; Neutropenia; Sarcoma; Thrombocytopenia; Time Factors | 1995 |
Busulfan-containing pre-transplant regimens for the treatment of solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasms; Ovarian Neoplasms; Pilot Projects; Retrospective Studies; Sarcoma | 1994 |
Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis.
Topics: DNA, Complementary; Drug Resistance; Etoposide; Female; Humans; Models, Statistical; Mutation; Polymerase Chain Reaction; Probability; RNA, Neoplasm; Sarcoma; Tumor Cells, Cultured; Uterine Neoplasms | 1994 |
17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
Topics: Cholestasis; Doxorubicin; Drug Resistance; Estradiol; Estriol; Etoposide; Humans; Leukemia, Myeloid; Paclitaxel; Sarcoma; Tumor Cells, Cultured; Vinblastine | 1993 |
21-day schedule oral etoposide in children--a feasibility study.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Leukemia; Leukopenia; Male; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Treatment Outcome | 1993 |
Ifosfamide-induced hyperpigmentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Humans; Hyperpigmentation; Ifosfamide; Infant; Male; Sarcoma; Time Factors | 1994 |
High-dose VP16 cisplatinum in soft tissue sarcoma of children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Male; Sarcoma; Treatment Outcome | 1994 |
[Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1993 |
24-hour plasma etoposide profile after oral and intravenous administration in children.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Etoposide; Humans; Injections, Intravenous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Soft Tissue Neoplasms; Time Factors | 1993 |
Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Metabolic Clearance Rate; Neoplasms; Neuroblastoma; Pineal Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Soft Tissue Neoplasms; Teratoma | 1993 |
Ifosfamide combination regimens for soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urologic Diseases | 1993 |
Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Urologic Diseases | 1993 |
Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Pilot Projects; Sarcoma; Treatment Outcome | 1993 |
Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
Topics: Antineoplastic Agents; Doxorubicin; Drug Resistance, Multiple; Etoposide; Guanidines; Humans; Paclitaxel; Polymers; Sarcoma; Spermine; Tumor Cells, Cultured; Vinblastine | 1996 |
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia | 1996 |
Etoposide for soft tissue sarcomas: fact or fiction.
Topics: Antineoplastic Agents, Phytogenic; Etoposide; Humans; Sarcoma; Soft Tissue Neoplasms | 1997 |
Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Germany; Humans; Hyperthermia, Induced; Ifosfamide; Male; Neuroectodermal Tumors; Prospective Studies; Recurrence; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Treatment Outcome | 1998 |
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gemcitabine; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 1998 |
Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Infant; Infant, Newborn; Meningeal Neoplasms; Pilot Projects; Rhabdomyosarcoma; Risk Factors; Sarcoma; Urogenital Neoplasms; Vincristine | 1998 |
Treatment of soft-tissue sarcomas: high-dose ifosfamide or combination of ifosfamide and etoposide?
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 1999 |
Role of the combination of ifosfamide and etoposide in the treatment of soft tissue sarcomas.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Sarcoma | 1999 |
Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Pilot Projects; Prospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Survival Analysis; Vincristine | 2000 |
Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia.
Topics: Adolescent; Adult; Aged; Albuminuria; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Creatinine; Etoposide; Female; Glomerular Filtration Rate; Glycoproteins; Humans; Hyperthermia, Induced; Ifosfamide; Immunoglobulin G; Kidney; Male; Membrane Glycoproteins; Middle Aged; Sarcoma; Trypsin Inhibitor, Kunitz Soybean | 2000 |
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Transfusion; Chi-Square Distribution; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Dactinomycin; Etoposide; Female; Fever; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Platelet Transfusion; Retrospective Studies; Sarcoma; Sepsis; Treatment Outcome; Vincristine | 2000 |
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Multidrug Resistance-Associated Proteins; Mutation; Neoplasm Proteins; Paclitaxel; Phenotype; Rhodamine 123; RNA, Messenger; Sarcoma; Tritium; Tumor Cells, Cultured; Uterine Neoplasms; Vault Ribonucleoprotein Particles; Vinblastine | 2000 |
[Bronchiolitis obliterans with organizing pneumonia secondary to chemotherapy in a child with primary pericardial sarcoma].
Topics: Antineoplastic Agents; Biopsy; Child, Preschool; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Doxorubicin; Etoposide; Heart Neoplasms; Humans; Male; Pericardium; Prednisolone; Sarcoma; Tomography, X-Ray Computed; Vincristine | 2000 |
Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Cycle; Cell Survival; Dioxoles; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Inhibitory Concentration 50; Isoquinolines; Methotrexate; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Sarcoma; Sensitivity and Specificity; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
[Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Sarcoma | 1992 |
Oral etoposide in treatment of advanced refractory sarcomas.
Topics: Administration, Oral; Etoposide; Humans; Sarcoma | 1992 |
High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Vincristine; Whole-Body Irradiation | 1992 |
Pilot study of a rapid etoposide-cisplatin regimen in paediatric soft tissue sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Male; Pilot Projects; Sarcoma; Soft Tissue Neoplasms | 1992 |
Poor prognosis of mediastinal germ cell cancers containing sarcomatous components.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Etoposide; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Prognosis; Sarcoma; Survival Rate; Vincristine | 1990 |
Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Middle Aged; Remission Induction; Sarcoma | 1991 |
Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Hyperthermia, Induced; Ifosfamide; Male; Mesna; Middle Aged; Regression Analysis; Sarcoma; Soft Tissue Neoplasms | 1990 |
Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin.
Topics: Bleomycin; Cell Line; Cell Survival; Doxorubicin; Drug Resistance; Etoposide; Humans; Mitomycin; Mitomycins; Mitotic Index; Oxygen; Sarcoma | 1987 |
Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Middle Aged; Remission Induction; Sarcoma | 1989 |
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Hematopoietic Stem Cells; Humans; Lung Neoplasms; Melanoma; Neoplastic Stem Cells; Sarcoma; Stem Cells | 1985 |
Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells.
Topics: Cefoperazone; Cell Survival; Chemical Phenomena; Chemistry; Doxorubicin; Drug Resistance; Etoposide; Humans; Sarcoma; Tumor Cells, Cultured; Vinblastine | 1989 |
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Combined Modality Therapy; Cystitis; Drug Evaluation; Etoposide; Humans; Ifosfamide; Mesna; Neoplasm Recurrence, Local; Sarcoma | 1987 |
Phase II trial of cisplatin and etoposide in children with advanced soft tissue sarcoma: a report from the Italian Cooperative Rhabdomyosarcoma Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Drug Evaluation; Etoposide; Humans; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms | 1987 |
VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1987 |
Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Humans; Infant; Neoplasm Recurrence, Local; Sarcoma | 1987 |